Company intelligence / Profile preview

Lishman Global

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Lishman Global is a medical technology company and strategic consultancy established in 2012 to facilitate the entry of foreign medical device companies into the Chinese market. The company operates a proprietary echocardiography image platform and maintains a GMP-certified manufacturing facility in China through its subsidiary. Lishman Global is a key strategic partner for Ventripoint Diagnostics, managing the regulatory submission and commercialization of the VMS+ 4.0 heart analysis system in China. Its expertise lies in navigating complex regulatory approvals, such as the NMPA "green channel" pathway, and managing multi-level distribution channels within the Chinese healthcare sector.

Therapeutic areas: Cardiovascular
Modalities: DeviceSoftware
Industry: Medical Imaging

Partnerships

Ventripoint Diagnostics

Beyond the preview

Go deeper on Lishman Global.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lishman Global.

Explore the full profile